2016 | 2017 | p-value | |
---|---|---|---|
Patients, N | 277 | 249 | |
Female, N (%) | 149 (53.4 %) | 136 (54.6 %) | 0.85 |
Mean age, years (Std Dev) | 57.9 (20.5) | 56.7 (21.1) | 0.46 |
BMI, N (%) | 0.75 | ||
< 25 | 121 (43.7 %) | 109 (43.8 %) | |
25.0–29.9 | 77 (27.8 %) | 60 (24.1 %) | |
30.0–34.9 | 36 (13.0 %) | 50 (20.1 %) | |
35.0–39.9 | 25 (9.0 %) | 20 (8.0 %) | |
> 40 | 18 (6.5 %) | 10 (4.0 %) | |
ASA Class, N (%) | 0.88 | ||
Class 1 | 7 (2.5 %) | 10 (4.0 %) | |
Class 2 | 94 (33.9 %) | 90 (36.1 %) | |
Class 3 | 141 (50.9 %) | 109 43.8 %) | |
Class 4 | 28 (10.1 %) | 32 (12.9 %) | |
Class 5 | 7 (2.5 %) | 8 (3.2 %) | |
Mean OR Time, Hr (Std Dev) | 2.3 | 2.2 | 0.49 |
Emergent, N (%) | 32 (11.6 %) | 27 (10.8 %) | 0.79 |